M*Modal Signs Interface License Agreement with 3M Health Information Systems

FRANKLIN, Tenn.--(BUSINESS WIRE)-- M*Modal (MModal Inc. - NASDAQ/GS: MODL), a leading provider of clinical documentation services, Speech Understanding™ and computer assisted coding technologies, today announced it has entered into a software interface license agreement (SILA) with 3M Health Information Systems. The agreement licenses the interfacing of M*Modal’s computer assisted coding solution to the 3M Coding and Reimbursement System.

“We are pleased to announce this agreement with 3M,” said Vern Davenport, Chairman and CEO of M*Modal. “M*Modal will be able to better support the healthcare community in its critical transition to ICD-10.”

About M*Modal

M*Modal is a leading provider of clinical narrative capture services, Speech and Natural Language Understanding technology with complementary clinical documentation workflow. M*Modal’s enterprise solutions – which include mobile voice capture devices, speech recognition, Natural Language Understanding, Web-based workflow platforms and a global network of medical editors – help healthcare organizations facilitate the adoption of electronic health records (EHRs), improve patient care, increase physician satisfaction and lower operational costs. For more information, please visit www.mmodal.com.

About 3M Health Information Systems

Best known for market-leading coding solutions and ICD-10 expertise, 3M Health Information Systems delivers innovative software and consulting services that raise the bar for clinical documentation improvement, computer-assisted coding, case mix and quality outcomes reporting, and a robust healthcare data dictionary and terminology services to support your EHR. With 28 years of coding experience and more than 100 credentialed coding experts, 3M is the go-to choice for 5,000+ hospitals worldwide that want to improve quality and financial performance.

Forward-Looking Statements

Information provided and statements contained in this press release that are not purely historical, such as statements regarding our expectations regarding our future business plans are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, specific factors discussed herein and in other releases and public filings made by the Company (including filings by the Company with the Securities and Exchange Commission). Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.



CONTACT:

Investor Contacts:
M*Modal
Ron Scarboro, 615-798-4350
Chief Financial Officer
[email protected]
or
Corporate Communications, Inc.
Tripp Sullivan, 615-324-7335
[email protected]
or
Media Contacts:
M*Modal
Joe McNamara, 267-535-6833
[email protected]
or
SHIFT Communications
Amanda Guisbond, 617-779-1813
[email protected]

KEYWORDS:   United States  North America  Tennessee

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

A New Orleans-based genetic testing company will pay $42.6 million to resolve False Claims Act and kickback allegations.

Virtual primary care is a new way to deliver healthcare.

FierceHealthcare caught up with former ONC and Veterans Affairs' official Genevieve Morris for our latest Executive Spotlight.